ALSO NOTED: Omrix CFO resigns; Marshall Edwards renegotiates payment; and much more...

> Chutes & Ladders: Omrix CFO Michael Burshtine has resigned, but will stay with the company until the end of August. Report

> Marshall Edwards has renegotiated its licensing payment on the anti-cancer therapy phenoxodiol with Novogen. Release

> The Robert Wood Johnson Foundation plans to commit $500 million to fight back against childhood obesity, which now afflicts about one third of the country's children. Article

And Finally… In Arizona, officials have taken the highly unusual and extreme step of jailing a 27-year-old tuberculosis patient who refuses to wear a mask in public to prevent the spread of the disease. Report

Suggested Articles

The clamor for more transparency from the leading pandemic vaccine contenders has been getting louder.

The role gives one of the driving forces behind Bristol Myers Squibb’s $74 billion takeover of Celgene the chance to help build biotechs.

The appointment gives Sino-American biotech Brii the experience of a man who helped Gilead launch eight drugs in China in quick succession.